G7
Device Hips
PDI 00889024578487
General payments
$87,604
Research payments
$94,006
Through program year 2025, $87,604 in general payments and $94,006 in research payments were reported against G7 (Hips).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $7,691 | 78 |
| 2024 | General | $862 | 19 |
| 2024 | Research | $37,602 | 2 |
| 2023 | General | $2,060 | 22 |
| 2023 | Research | $18,801 | 1 |
| 2022 | General | $76,991 | 26 |
| 2022 | Research | $37,602 | 2 |
Breakdown
The top 5 of 65 recipients; each share is of general payments naming this product in 2025.
The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 20 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
145 general · 5 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.